FLONASE ALLERGY RELIEF Drug Patent Profile
✉ Email this page to a colleague
When do Flonase Allergy Relief patents expire, and when can generic versions of Flonase Allergy Relief launch?
Flonase Allergy Relief is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in FLONASE ALLERGY RELIEF is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flonase Allergy Relief
A generic version of FLONASE ALLERGY RELIEF was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
Summary for FLONASE ALLERGY RELIEF
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 24 |
Patent Applications: | 4,474 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FLONASE ALLERGY RELIEF |
DailyMed Link: | FLONASE ALLERGY RELIEF at DailyMed |
Recent Clinical Trials for FLONASE ALLERGY RELIEF
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Andover Research Eye Institute | Phase 4 |
University of South Florida | Phase 3 |
St. Paul's Sinus Centre | Phase 4 |
Pharmacology for FLONASE ALLERGY RELIEF
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FLONASE ALLERGY RELIEF
US Patents and Regulatory Information for FLONASE ALLERGY RELIEF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | FLONASE ALLERGY RELIEF | fluticasone propionate | SPRAY, METERED;NASAL | 205434-001 | Jul 23, 2014 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |